|1.||Canfield, P J: 3 articles (03/2011 - 01/2011)|
|2.||Lepherd, M L: 3 articles (03/2011 - 01/2011)|
|3.||Thomson, P C: 3 articles (03/2011 - 01/2011)|
|4.||Bosward, K L: 3 articles (03/2011 - 01/2011)|
|5.||Hunt, G B: 3 articles (03/2011 - 01/2011)|
|6.||George, Roy: 2 articles (08/2014 - 12/2008)|
|7.||Walsh, Laurence J: 2 articles (08/2014 - 12/2008)|
|8.||Poggio, Claudio: 2 articles (06/2012 - 09/2011)|
|9.||Scribante, Andrea: 2 articles (06/2012 - 09/2011)|
|10.||Baie, S H: 2 articles (11/2000 - 07/2000)|
|1.||Wounds and Injuries (Trauma)
03/01/2011 - "Both mulesing and the cetrimide-intradermal treatment induce a similar amount of wound bed contraction, with less contraction observed after application of clips."
03/01/2011 - "Mulesing wounds healed faster in the first 11 days, but by 19 days wound healing was similar between the mulesing and cetrimide-intradermal groups. "
03/01/2011 - "To quantify wound healing using a scoring system and to assess the contractility of the wound bed of the breech after mulesing, cetrimide-intradermal treatment and application of clips. "
11/01/2000 - "The wound healing properties of Channa striatus-cetrimide cream-wound contraction and glycosaminoglycan measurement."
06/01/2010 - "Cetrimide is a monocationic surfactant, commonly used for disinfection of hospital floors, equipments, for cleansing of burns and wounds, hand wash, etc. We evaluated whether antibiotic resistant (AR) Escherichia coli isolates from hospital settings (nosocomial pathogens) show any evidence of significant reduction in their susceptibility to cetrimide. "
10/01/2012 - "In part 1, cementum was removed semicircumferentially from 21 roots, and the smear layer was removed from 15 roots using 17% EDTA/cetrimide. "
12/01/2008 - "Lasing improved the action of ethylene diamine tetraacetic acid with cetavlon (EDTAC) in removing smear layer. "
12/01/2012 - "Evaluation of smear layer removal by bicarbonate soda, ethylenediamine tetraacetic acid with cetrimide and sodium hypochlorite with a new model."
01/01/2000 - "Quantitative evaluation of smear layer removal, measured as open tubules/total dentinal surface ratio, showed that 1 mol L-1 citric acid solution was comparable to EDTA (11.97% vs. 10.36%) (NS); in samples treated with ProFile .04 taper instruments citric acid was most effective (16.17%), whilst in the group treated with manual instrumentation EDTA and Cetrimide were the most effective (11.94%). "
01/01/2013 - "Comparative evaluation of 15% ethylenediamine tetra-acetic acid plus cetavlon and 5% chlorine dioxide in removal of smear layer: A scanning electron microscope study."
11/01/1962 - "Treatment of primary and secondary infections of the skin with cetyltrimethylammonium bromide."
01/01/2003 - "We found that the transient expression activity of luciferase could not be augmented directly by CTAB treatment alone, but could be enhanced more than 2 times by BmNPV treatment alone at a multiplicity of infection (MOI) of 0.5. "
06/01/1993 - "Little cross-reactivity with other common porcine helminth infections appeared only when ELISA was carried out with CSLE and CTAB antigens."
11/01/1986 - "CTAB antigen preparations were shown to be protective in NIH mice against a challenge infection as assessed by reduction in intestinal worm burden, worm fecundity, worm length and muscle larvae burden. "
07/01/2000 - "In conclusion, our study showed that contaminated chlorhexidine-cetrimide solution was the source of a bacteremic outbreak in nine patients who developed catheter-related Burkholderia cepacia infection."
07/15/2015 - "Furthermore, the PTX/TET-CTAB@MSN suppressed tumor cells growth more efficiently than only delivery of PTX (PTX-CTAB@MSN) or the free PTX. "
10/01/2011 - "The in vitro cytotoxicity of CTAB-NES to the CHO cells and MCF-7 cells increased consistently with concentrations and was higher than that of NES, especially to the cancer cells. "
10/01/2011 - "The nano-MDDS DOX@CTAB@MSNs had a highly precise pH-responsive drug release behavior both in vitro and in vivo, and exhibited high drug efficiencies against drug-resistant MCF-7/ADR cells as well as drug-sensitive MCF-7 cells by the MSNs-mediated transmembrane delivery, the sustained drug release and the high anti-cancer and multi-drug resistance (MDR)-overcoming efficiencies. "
11/01/2009 - "In vivo, CTAB ablated tumor-forming capacity of FaDu cells and delayed growth of established tumors. "
11/01/2009 - "CTAB exhibited anticancer cytotoxicity against several HNC cell lines, with minimal effects on normal fibroblasts; a selectivity that exploits cancer-specific metabolic aberrations. "
|5.||Echinococcosis (Hydatid Cysts)
01/01/1981 - "Treatment of hydatid cysts (Echinococcus granulosus) by Cetrimide (R)."
07/12/1980 - "Cetrimide-induced methaemoglobinaemia after surgical excision of hydatid cyst."
01/01/1978 - "Scolicidal effects of Cetrimide (R) on hydatid cyst (Echinococcus granulosus)."
11/01/1994 - "Coma and haemolysis after cetrimide washout of epidural hydatid cyst."
09/01/1998 - "Efficacy of cetrimide-chlorhexidine combination in surgery for hydatid cyst."
|3.||Hydrogen Peroxide (Hydroperoxide)
|5.||Edetic Acid (EDTA)
|6.||Acetic Acid (Vinegar)
|7.||ethylenediamine (ethylenediamine dihydroiodide)
|10.||Bupivacaine (Bupivacaine Hydrochloride)
|4.||Transplantation (Transplant Recipients)